Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Injectable drugs like Ozempic and Wegovy may be new to most of the world, but the science behind them are familiar to those in the health field.
Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...
— Days after retaining the Nickles Group, Novo Nordisk also hired Checkmate Government Relations, the new D.C. outpost of a ...
Excess weight can trigger chronic low-grade inflammation, which has been linked to increased risk for conditions such as heart disease and dementia. GLP-1s work by suppressing appetite and making ...
Scientists have discovered a naturally-occurring molecule that rivals the weight-loss effects of semaglutide-based GLP-1s like Ozempic in animals.
The rumoured cold war between Ekta Kapoor and Ram Kapoor escalates as Ekta’s cryptic weight loss video sparks speculation.
The global obsession with weight-loss drugs is reaching unprecedented levels, reshaping industries, economies, and even our ...
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
Ekta Kapoor seems to be still upset with Ram Kapoor as she had taken an indirect dig at his weight loss amid their public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results